Drugs / beclamethasone dipropionate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02499887 | Jan → Sep 2016 | asthma, chronic obstructive pulmonary disease | State University of New York at Buffalo | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | beclamethasone dipropionate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02499887 ↗ |
| Route | Inhaled | “30 day QVAR® (beclamethasone dipropionate) inhaler (80 mcg, 1 puff twice daily)” NCT02499887 ↗ |